Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis

Endocrinology

Volumn 150, Issue 11, 2009, Pages 4931-4940

  Badman, Michael K ^a   Koester, Anja ^c   Flier, Jeffrey S ^a,b   Kharitonenkov, Alexei ^c   Maratos Flier, Eleftheria ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CHOLESTEROL; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIET RESTRICTION; DISEASE PREDISPOSITION; ENERGY METABOLISM; FATTY LIVER; FEEDING; GENE DISRUPTION; GENE FUNCTION; GENE LOCUS; GLUCOSE HOMEOSTASIS; KETOACIDOSIS; KETOGENESIS; LIPID OXIDATION; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; STARVATION; WEIGHT GAIN; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY LIVER; FEMALE; FIBROBLAST GROWTH FACTORS; GENE SILENCING; GLUCOSE; HUMANS; KETOGENIC DIET; KETOSIS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 70350322694     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0532     Document Type: Article

References (28)

1. Moore DD 2007 Physiology. Sister act. Science 316:1436-1438
2. Kurosu H, Kuro-O M 2009 The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 299:72-78
3. Nishimura T, Nakatake Y, Konishi M, Itoh N 2000 Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492:203-206 (Pubitemid 30349198)
4. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB 2005 FGF-21 as a novel metabolic regulator. J Clin Invest 115:1627-1635
5. Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ 2007 The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148:774-781 (Pubitemid 46143178)
6. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A 2008 Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149:6018-6027
7. Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Véniant MM 2009 Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58:250-259
8. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E 2007 Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5:426-437 (Pubitemid 46825495)
9. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA 2007 Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab 5:415-425 (Pubitemid 46825496)
10. Lundåsen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M 2007 PPARα is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 360:437-440 (Pubitemid 47039157)
11. Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller A, Kharitonenkov A 2007 Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARγ signaling. J Cell Physiol 210:1-6 (Pubitemid 44904695)
12. Muise ES, Azzolina B, Kuo DW, El Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR, Berger JP, Wong KK 2008 Adipose fibroblast growth factor 21 is up-regulated by PPARγ and altered metabolic states. Mol Pharmacol 74:403-412
13. Chen WW, Li L, Yang GY, Li K, Qi XY, Zhu W, Tang Y, Liu H, Boden G 2008 Circulating FGF-21 levels in normal subjects and in newly diagnosed patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 116:65-68 (Pubitemid 351270911)
14. Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A 2008 Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57:1246-1253
15. Wente W, Efanov AM, Brenner M, Kharitonenkov A, Köster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J 2006 Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55:2470-2478 (Pubitemid 44871147)
16. Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M 2007 βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci USA 104:7432-7437 (Pubitemid 47185923)
17. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M 2007 Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282:26687-26695 (Pubitemid 47501965)
18. Kharitonenkov A, Dunbar JD, Bina HA, Bright S, Moyers JS, Zhang C, Ding L, Micanovic R, Mehrbod SF, Knierman MD, Hale JE, Coskun T, Shanafelt AB 2008 FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho. J Cell Physiol 215:1-7 (Pubitemid 351363185)
19. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T 2008 βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22:1006-1014
20. Kennedy AR, Pissios P, Otu H, Xue B, Asakura K, Furukawa N, Marino FE, Liu FF, Kahn BB, Libermann TA, Maratos-Flier E 2007 A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab Errata (2007) 293:E1846 and (2009) 296:E1179 292:E1724-E1739 (Pubitemid 47084708)
21. Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, Wang X, Bates S, Myers Jr MG, Flier JS, Maratos-Flier E 2003 Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA 100:10085-10090 (Pubitemid 37087071)
22. Kokkotou E, Jeon JY, Wang X, Marino FE, Carlson M, Trombly DJ, Maratos-Flier E 2005 Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 289:R117-R124 (Pubitemid 40874966)
23. Wang H, Qiang L, Farmer SR 2008 Identification of a domain within peroxisome proliferator-activated receptor γ regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 28:188-200
24. Koester A, Broderick CL, Chen Y, Kharitonenkov A, Ford A 2006 Metabolic evaluation of FGF-21 transgenic mice. Diabetologia 49(Suppl 1):352
25. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL 1996 Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575-1584 (Pubitemid 26327867)
26. Brown MS, Goldstein JL 1999 A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11041-11048
27. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N 2002 Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277:19353-19357 (Pubitemid 34967441)
28. Horton JD, Shimomura I, Ikemoto S, Bashmakov Y, Hammer RE 2003 Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem 278:36652-36660 (Pubitemid 37139997)